ACCELERATION OF THE BODY CLEARANCE OF PHENOBARBITAL BY ORAL ACTIVATED-CHARCOAL

被引:147
作者
BERG, MJ
BERLINGER, WG
GOLDBERG, MJ
SPECTOR, R
JOHNSON, GF
机构
[1] UNIV IOWA, DEPT MED, IOWA CITY, IA 52242 USA
[2] UNIV IOWA, DEPT PHARMACOL, IOWA CITY, IA 52242 USA
[3] UNIV IOWA, DEPT PHARM, IOWA CITY, IA 52242 USA
[4] UNIV IOWA, DEPT PATHOL, IOWA CITY, IA 52242 USA
关键词
D O I
10.1056/NEJM198209093071102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of multiple oral doses of activated charcoal on the pharmacokientics of i.v. phenobarbital was studied in a randomized crossover trial. Six healthy men volunteered to take 200 mg phenobarbital sodium/70 kg body wt i.v. on 2 separate occasions. Each subject received oral activated charcoal (180 g) in divided doses over 3 days after the infusion of phenobarbital. Serum levels of phenobarbital were measured in all subjects up to 90 h after the infusion, and urinary excretion of phenobarbital was measured in 2 subjects 24-96 h after the infusion. A pharmacokinetic analysis showed that the charcoal decreased the serum half-life of phenobarbital from 110 .+-. 8 to 45 .+-. 6 h (P < 0.01), increased the total body clearance of phenobarbital from 4.4 .+-. 0.2 to 12.0 .+-. 1.6 ml/kg per h (P < 0.01) and increased the nonrenal clearance from 52 to 80% of the total body clearance. Evidently, oral administration of activated charcoal enhances the nonrenal cleareance of phenobarbital.
引用
收藏
页码:642 / 644
页数:3
相关论文
共 17 条
[11]   EFFECT OF ACTIVATED-CHARCOAL ON ABSORPTION AND ELIMINATION OF PHENOBARBITONE, CARBAMAZEPINE AND PHENYLBUTAZONE IN MAN [J].
NEUVONEN, PJ ;
ELONEN, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (01) :51-57
[12]  
POND S, 1981, LANCET, V2, P1177
[13]   BARBITURATE INTOXICATION - EVALUATION OF THERAPY INCLUDING DIALYSIS IN A LARGE SERIES SELECTIVELY REFERRED BECAUSE OF SEVERITY [J].
SETTER, JG ;
MAHER, JF ;
SCHREINER, GE .
ARCHIVES OF INTERNAL MEDICINE, 1966, 117 (02) :224-+
[14]  
TANG BK, 1979, DRUG METAB DISPOS, V7, P315
[15]   PHARMACOKINETICS OF PHENOBARBITAL FOLLOWING SINGLE AND REPEATED DOSES [J].
VISWANATHAN, CT ;
BOOKER, HE ;
WELLING, PG .
JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 19 (5-6) :282-289
[16]  
Wagner JG., 1975, Fundamentals of clinical pharmacokinetics
[17]  
Yatzidis H., 1971, ACUTE BARBITURATE PO, P223